- Author:
Qian LI
1
;
Yun'ai SU
1
;
Xuemei LIAO
1
;
Maosheng FANG
2
;
Jianliang GAO
3
;
Jia XU
4
;
Mingjun DUAN
5
;
Haiying YU
6
;
Yang YANG
7
;
Zhiyu CHEN
8
;
Jintong LIU
9
;
Shaoxiao YAN
10
;
Peifen YAO
11
;
Shuying LI
12
;
Changhong WANG
13
;
Bin WU
14
;
Congpei ZHANG
4
;
Tianmei SI
1
Author Information
- Publication Type:Letter
- MeSH: Humans; Aripiprazole/therapeutic use*; Schizophrenia/drug therapy*; Antipsychotic Agents/therapeutic use*; Risperidone; China; Treatment Outcome
- From: Chinese Medical Journal 2023;136(9):1126-1128
- CountryChina
- Language:English